Cargando…

KSHV ORF57, a Protein of Many Faces

Kaposi’s sarcoma-associated herpesvirus (KSHV) ORF57 protein (also known as mRNA transcript accumulation (Mta)) is a potent posttranscriptional regulator essential for the efficient expression of KSHV lytic genes and productive KSHV replication. ORF57 possesses numerous activities that promote the e...

Descripción completa

Detalles Bibliográficos
Autores principales: Majerciak, Vladimir, Zheng, Zhi-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4353906/
https://www.ncbi.nlm.nih.gov/pubmed/25674768
http://dx.doi.org/10.3390/v7020604
_version_ 1782360668110848000
author Majerciak, Vladimir
Zheng, Zhi-Ming
author_facet Majerciak, Vladimir
Zheng, Zhi-Ming
author_sort Majerciak, Vladimir
collection PubMed
description Kaposi’s sarcoma-associated herpesvirus (KSHV) ORF57 protein (also known as mRNA transcript accumulation (Mta)) is a potent posttranscriptional regulator essential for the efficient expression of KSHV lytic genes and productive KSHV replication. ORF57 possesses numerous activities that promote the expression of viral genes, including the three major functions of enhancement of RNA stability, promotion of RNA splicing, and stimulation of protein translation. The multifunctional nature of ORF57 is driven by its ability to interact with an array of cellular cofactors. These interactions are required for the formation of ORF57-containing ribonucleoprotein complexes at specific binding sites in the target transcripts, referred as Mta-responsive elements (MREs). Understanding of the ORF57 protein conformation has led to the identification of two structurally-distinct domains within the ORF57 polypeptide: an unstructured intrinsically disordered N-terminal domain and a structured α-helix-rich C-terminal domain. The distinct structures of the domains serve as the foundation for their unique binding affinities: the N-terminal domain mediates ORF57 interactions with cellular cofactors and target RNAs, and the C-terminal domain mediates ORF57 homodimerization. In addition, each domain has been found to contribute to the stability of ORF57 protein in infected cells by counteracting caspase- and proteasome-mediated degradation pathways. Together, these new findings provide insight into the function and biological properties of ORF57 in the KSHV life cycle and pathogenesis.
format Online
Article
Text
id pubmed-4353906
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-43539062015-04-10 KSHV ORF57, a Protein of Many Faces Majerciak, Vladimir Zheng, Zhi-Ming Viruses Review Kaposi’s sarcoma-associated herpesvirus (KSHV) ORF57 protein (also known as mRNA transcript accumulation (Mta)) is a potent posttranscriptional regulator essential for the efficient expression of KSHV lytic genes and productive KSHV replication. ORF57 possesses numerous activities that promote the expression of viral genes, including the three major functions of enhancement of RNA stability, promotion of RNA splicing, and stimulation of protein translation. The multifunctional nature of ORF57 is driven by its ability to interact with an array of cellular cofactors. These interactions are required for the formation of ORF57-containing ribonucleoprotein complexes at specific binding sites in the target transcripts, referred as Mta-responsive elements (MREs). Understanding of the ORF57 protein conformation has led to the identification of two structurally-distinct domains within the ORF57 polypeptide: an unstructured intrinsically disordered N-terminal domain and a structured α-helix-rich C-terminal domain. The distinct structures of the domains serve as the foundation for their unique binding affinities: the N-terminal domain mediates ORF57 interactions with cellular cofactors and target RNAs, and the C-terminal domain mediates ORF57 homodimerization. In addition, each domain has been found to contribute to the stability of ORF57 protein in infected cells by counteracting caspase- and proteasome-mediated degradation pathways. Together, these new findings provide insight into the function and biological properties of ORF57 in the KSHV life cycle and pathogenesis. MDPI 2015-02-10 /pmc/articles/PMC4353906/ /pubmed/25674768 http://dx.doi.org/10.3390/v7020604 Text en © 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Majerciak, Vladimir
Zheng, Zhi-Ming
KSHV ORF57, a Protein of Many Faces
title KSHV ORF57, a Protein of Many Faces
title_full KSHV ORF57, a Protein of Many Faces
title_fullStr KSHV ORF57, a Protein of Many Faces
title_full_unstemmed KSHV ORF57, a Protein of Many Faces
title_short KSHV ORF57, a Protein of Many Faces
title_sort kshv orf57, a protein of many faces
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4353906/
https://www.ncbi.nlm.nih.gov/pubmed/25674768
http://dx.doi.org/10.3390/v7020604
work_keys_str_mv AT majerciakvladimir kshvorf57aproteinofmanyfaces
AT zhengzhiming kshvorf57aproteinofmanyfaces